CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Respiratory syncytial virus infection and risk of acute myocardial infarction Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial Restenosis, Stent Thrombosis, and Bleeding Complications - Navigating Between Scylla and Charybdis 2023 ESC Guidelines for the management of acute coronary syndromes Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown Unknowns Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents: Insights of the TROFI II Trial Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial

Review Article2020 Jun 27;9(7):E2020.

JOURNAL: J Clin Med . Article Link

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome

W Bor, DA Gorog. Keywords: NOAC; ACS; antiplatelet therapy; antithrombotic therapy; atrial fibrillation; dual therapy; oral anticoagulants; percutaneous coronary intervention; triple therapy; vitamin K antagonist

Full Text PDF